ALPHA-2B
MOLECULAR TARGETAlpha-2B adrenergic receptor (human)
ALPHA-2B (Alpha-2B adrenergic receptor (human)) is targeted by 39 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ALPHA-2B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Yohimbine | 2.20 | 8 |
| 2 | Clonidine | 1.79 | 5 |
| 3 | Guanfacine | 1.39 | 3 |
| 4 | Mianserin | 1.10 | 2 |
| 5 | Quetiapine Fumarate | 1.10 | 2 |
| 6 | Sertraline | 1.10 | 2 |
| 7 | Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent | 1.10 | 2 |
| 8 | Amoxapine | 1.10 | 2 |
| 9 | Astemizole Antihistamine drug now withdrawn from | 1.10 | 2 |
| 10 | Bromocriptine | 1.10 | 2 |
| 11 | Carvedilol | 1.10 | 2 |
| 12 | Celecoxib | 1.10 | 2 |
| 13 | Cinnarizine | 1.10 | 2 |
| 14 | Clotrimazole | 1.10 | 2 |
| 15 | Cyproheptadine | 1.10 | 2 |
| 16 | Dexmedetomidine | 1.10 | 2 |
| 17 | Dihydroergotamine | 1.10 | 2 |
| 18 | Dimenhydrinate | 1.10 | 2 |
| 19 | Disulfiram | 1.10 | 2 |
| 20 | Domperidone | 1.10 | 2 |
| 21 | Econazole | 1.10 | 2 |
| 22 | Epinephrine | 1.10 | 2 |
| 23 | Ergonovine | 1.10 | 2 |
| 24 | Ergotamine | 1.10 | 2 |
| 25 | Flunarizine Flunarizine is | 1.10 | 2 |
| 26 | Guanabenz | 1.10 | 2 |
| 27 | Lisuride | 1.10 | 2 |
| 28 | Maprotiline | 1.10 | 2 |
| 29 | Metergoline | 1.10 | 2 |
| 30 | Methylergonovine | 1.10 | 2 |
| 31 | Methysergide | 1.10 | 2 |
| 32 | Miconazole | 1.10 | 2 |
| 33 | Nortriptyline | 1.10 | 2 |
| 34 | Oxymetazoline | 1.10 | 2 |
| 35 | Pergolide | 1.10 | 2 |
| 36 | Phentolamine | 1.10 | 2 |
| 37 | Promethazine | 1.10 | 2 |
| 38 | Trazodone | 1.10 | 2 |
| 39 | Norepinephrine Precursor of epinephrine that is secreted by | 0.69 | 1 |
About ALPHA-2B as a Drug Target
ALPHA-2B (Alpha-2B adrenergic receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 39 compounds with documented ALPHA-2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ALPHA-2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.